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 There is little disagreement about the societal burden of out-of-hospital cardiac arrest (OHCA) in 
terms of both high mortality and morbidity.1 Previous studies on OHCA outcomes were hampered 
by the variability in the definitions and reporting of patient outcome; however, in recent decades, 
with the publication and adoption of the uniform ‘Utstein style’ reporting guidelines,2 several large 
observational studies have outlined the OHCA outcomes in Europe and elsewhere.3-6 Not a moment 
too soon, a clear shift has also occurred towards including neurological outcomes and patient quality 
of life in these reports.7 Less attention, however, has been focused on health care costs and 
especially on the cost-effectiveness of out-of-hospital cardiopulmonary resuscitation (CPR) and 
various adopted cardiac arrest interventions.8-10 A major challenge in cost data collection is the 
multidisciplinary teams involved in the care of OHCA patients. The exact per patient cost figures 
may be impossible to collect from emergency medical service (EMS) providers, hospitals and the 
involved insurance companies. On the contrary, this problem may not be unique to OHCA but may 
be typical for many other types of critical illness and for pre-hospital care in general.  
 In this issue of Resuscitation, Geri and colleagues have made an effort to accurately estimate the 
health costs related to cardiac arrest including pre-hospital and hospital care in Ontario, Canada 
over an eight-year period11. Using prospectively collected OHCA data from a well-established 
database and by combining these data with the data on EMS and hospital and outpatient care costs 
obtained from state-wide health care databases, the authors aimed to measure health care costs 
after cardiac arrest from a payer’s perspective. In a study involving more than 25,000 cardiac arrest 
patients, they investigate the factors associated with total costs primarily from both an EMS and a 
hospital perspective. The authors estimate that during the eight-year study period, 160 million 
Canadian Dollars (CAD) were spent on OHCA management with a gradual increase in yearly costs 
over time. The pre-hospital costs including the care cost of patients who died on scene account for 
only 6% of the total costs whereas 92-93 % are related to hospital care. Indeed the main conclusion 
of the study, based on these findings is that initial survival is the main contributor to the total costs 
after OHCA. Whilst this conclusion may seem completely expected and self-evident at first, it has 
important layers. The most important point that needs to be acknowledged is a form of 
“survivorship bias”. Many of the interventions such as summoning more EMS teams to the scene, 
TTM, angiography and CABG are offered in order to improve the chances of survival and some are 
applied at a time when other patients will have already succumbed. That time bias immediately 
makes the total costs of these patients a little higher and, if these interventions are effective, these 
patients will survive to need more care and this results in higher costs.    
 The main and simple question that arises with an analysis such as this is whether all these dollars 
are really well spent. A simple way of answering this would be to divide the total sum of 160 million 
CAD with the total 2100 OHCA patients alive at 30 days. This would result in a sum of ~80,000 CAD 
per survivor. This cost would be seen by most as well below what is considered acceptable in 
medicine today.12 However, unfortunately, we know that rehabilitation costs and work 
compensations are considerable in OHCA patients and that the total costs for the former are likely 
to be much higher than the reported 80,000 CAD for the first thirty days.9 In addition, the study does 
not report on the neurological outcomes of patients. Patients with poor outcomes and a cerebral 
performance category scale of 3–4 have very high rehabilitation costs and are unlikely to return to 
work.9,13 Thus, the final possible cost per quality-adjusted life year is difficult to estimate based on 
the current study. Nevertheless, based on previous studies, we know that from an intensive care 
unit (ICU) perspective, the cost-effectiveness of ICU care for OHCA patients appears very similar to 
other types of neurocritical illnesses, including traumatic brain injury, stroke and subarachnoid 
haemorrhage.14,15   
 
 The authors discuss means to decrease costs. Regarding pre-hospital costs, the amount of on scene 
teams, greatly increases costs. However, if as the authors suggest, this results in improved survival 
and even better neurological outcome this is very much likely to be cost effective16. One main 
contributor to increased hospital costs that was identified by the authors is the need for secondary 
transport. This may, though, be a modifiable aspect of OHCA management. In some instances, direct 
transport to a cardiac arrest centre may be justified, even though high quality data on this topic is 
lacking.17 The use of TTM also clearly increases costs, but if it increases the number of patients with 
good neurological outcome, as an intervention, it is likely very cost-effective.18 Other future aspects 
of care such as a more widespread use of extracorporeal CPR make this even more complex.19 
Moreover, the possible opportunity of organ donation in patients with catastrophic brain injury such 
as brain death, is likely to improve the cost-effectiveness of OHCA from a societal perspective.   
 How can we make OHCA management more cost-effective? This is of relevance, given the rise in 
health expenditure overall and taking into account the aging population in the western world. Based 
on the findings of Geri and colleagues, a focus on the basic steps of the chain of survival is likely the 
answer, but the need for strategies aiming at identifying futile care at all steps should not be 
ignored.20,21 Geri and colleagues should be congratulated for attempting to provide important 
information on the OHCA management costs. Only with larger and more comprehensive studies 
including data on long-term neurological outcome can the total cost of this very complex problem 
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